Research Article
Prevalence of Angiogenesis, Proliferation, and Apoptosis Markers of Cervical Cancer and Their Correlation with Clinicopathological Parameters
Table 2
Summary statistics of cancer-related markers.
| | Biomarker intensity | Value N (%) |
| | Angiogenesis markers | |
| | Vascular endothelial growth factor (VEGF) | |
| | Mild | 2 (3.33%) |
| | Moderate | 4 (6.67%) |
| | Negative | 20 (33.33%) |
| | Strong | 10 (16.67%) |
| | Platelet-derived growth factor (PDGF) | |
| | Moderate | 1 (1.67%) |
| | Negative | 33 (55.00%) |
| | Strong | 2 (3.33%) |
| | Angiogenesis inhibitor markers | |
| | Angiostatin | |
| | Mild | 6 (10.00%) |
| | Moderate | 4 (6.67%) |
| | Negative | 26 (72.22%) |
| | Endostatin | |
| | Mild | 7 (11.67%) |
| | Moderate | 9 (15.00%) |
| | Negative | 15 (25.00%) |
| | Strong | 5 (8.33%) |
| | Proliferation marker | |
| | KI67 | |
| | Moderate | 1 (1.67%) |
| | Negative | 3 (5.00%) |
| | Strong | 56 (93.33%) |
| | Apoptosis marker | |
| | p53 | |
| | Moderate | 13 (21.67%) |
| | Negative | 12 (20.00%) |
| | Strong | 35 (58.33%) |
| | p16 | |
| | Mild | 1 (1.67%) |
| | Moderate | 17 (28.33%) |
| | Negative | 3 (5.00%) |
| | Strong | 39 (65.00%) |
|
|
